Raymond James & Associates’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-777
Closed -$114K 3875
2022
Q4
$114K Buy
+777
New +$114K ﹤0.01% 3575